Biomarker-Guided Drug Delivery Systems and Oral Bioavailability Enhancement
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 129
Special Issue Editors
Interests: drug delivery; nanoparticles; formulation; analytical chemistry; LC-MS/MS; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomarker-guided drug delivery systems and oral bioavailability enhancement synergy are transforming precision medicine. Through patient-specific biomarkers, new drug formulations can be tailored to improve therapeutic efficacy with fewer side effects. Predictive modeling and artificial intelligence-based models increasingly play more vital roles in creating oral drug delivery strategies depending on patient response.
Recent drug delivery technology developments, such as lipid- and polymer-based nanosystems, have increased oral bioavailability and drug absorption efficiency. Biomarker uses in drug delivery are revolutionizing personalized medicine through controlled and targeted drug release, better pharmacokinetics, and reduced variability in patient response.
This Special Issue will feature state-of-the-art research on biomarker-guided drug delivery systems, precision medicine, and formulation strategies for oral bioavailability enhancement. We welcome original research articles, reviews, and short communications discussing biomarker-guided solutions for oral bioavailability enhancement, personalized oral drug delivery, and new predictive analytic strategies for formulation development. Articles covering the use of AI and machine learning for drug absorption optimization are also welcome.
We anticipate your important contributions toward shaping the future of biomarker-driven precision drug delivery.
Dr. Van-An Duong
Dr. Dang-Khoa Vo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarker-guided delivery
- personalized medicine
- oral drug bioavailability
- targeted drug formulations
- nanocarrier
- advanced drug carriers
- predictive pharmacokinetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
